Farenzena, N. and Fröhlich, A. C. (2023) “Evaluation of the use of CGRP monoclonal antibodies (mAbs) in migraine prophylaxis in a private clinic”, Headache Medicine, 14(2), pp. 83–88. doi: 10.48208/HeadacheMed.2023.17.